Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddys Laboratories informs about press release
Date: 06-06-2017Dr. Reddys Laboratories has informed about a press release titled ‘Dr. Reddys Laboratories announces the launch of Bivalirudin for Injection in the US Market’.
The above information is a part of company’s filings submitted to BSE.